Register entry
CHIESI FARMACEUTICI SPA
- Registered sites
- 0
- Drug products
- 0
- Live patents
- 46
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
46Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| FILSUVEZ | BIRCH TRITERPENES | Jun 2027 |
| FILSUVEZ | BIRCH TRITERPENES | Nov 2030 |
| FILSUVEZ | BIRCH TRITERPENES | Jan 2039 |
| JUXTAPID | LOMITAPIDE MESYLATE | Aug 2027 |
| JUXTAPID | LOMITAPIDE MESYLATE | Jul 2041 |
| MYCAPSSA | OCTREOTIDE ACETATE | Sept 2029 |
| MYCAPSSA | OCTREOTIDE ACETATE | Feb 2036 |
| MYCAPSSA | OCTREOTIDE ACETATE | Dec 2040 |
| TRIMBOW | BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | Dec 2030 |
| TRIMBOW | BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | Dec 2034 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.